Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
CASE REPORTS
Malignant Gastrointestinal Stromal Tumor of the Small Intestine Complicated with Pulmonary Tuberculosis during Treatment with Imatinib Mesylate
Mototsugu TAKASHIMANaoya IGAKITomokazu MATSUDAMinako OHYAMASuirin KANDAFumihiko TAMADATakeo GOTO
Author information
JOURNAL OPEN ACCESS

2005 Volume 44 Issue 2 Pages 114-119

Details
Abstract

We describe a patient who had a metastatic gastrointestinal stromal tumor (GIST) after previous failed extensive therapy, including multiple surgeries and hepatic artery embolization. Within a few months of starting administration of imatinib mesylate, the patient exhibited a clinical response with grade 3 neutropenia, when pulmonary tuberculosis developed. A c-kit mutation in exon 11 was detected only in metastatic liver specimens. It is unclear whether or not pulmonary tuberculosis may be induced by imatinib mesylate treatment, but caution is warranted in immunocompromised GIST patients. This is the first report of tuberculosis associated with neutropenia during imatinib mesylate treatment.

Content from these authors
© 2005 by The Japanese Society of Internal Medicine
Previous article Next article
feedback
Top